Zevra Therapeutics, Inc. (ZVRA)
8.33
-0.06
(-0.72%)
USD |
NASDAQ |
Dec 12, 11:32
Zevra Therapeutics Research and Development Expense (TTM): 16.83M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Nektar Therapeutics | 116.36M |
| XOMA Royalty Corp. | 2.295M |
| Akebia Therapeutics, Inc. | 42.02M |
| NovaBay Pharmaceuticals, Inc. | -- |
| Palatin Technologies, Inc. | 11.68M |